DAILYZ HEALTH NEWS

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

The Biden administration announced a plan to cap insulin out-of-pocket costs at $35 monthly for all insured Americans, expanding beyond Medicare.

As of mid-2026, the FDA has not approved any gene-editing therapies for type 1 diabetes, with such treatments still in preclinical stages.

A six-month trial in NEJM found hybrid closed-loop insulin pumps improved A1c and reduced severe hypoglycemia in type 1 diabetes patients.

The FDA has not approved RebiQuent for moderate to severe atopic dermatitis; current oral treatments include abrocitinib and upadacitinib.

UnitedHealth’s Change Healthcare unit suffered a ransomware attack exposing data of 4.2 million patients; a $22 million ransom was paid.

A study finds changes in two blood proteins enable over 90% accurate early detection and monitoring of aggressive glioblastoma brain cancer.

The WHO launched clinical trials for Bundibugyo virus Ebola treatments and vaccines following outbreaks in the DRC and Uganda.

A Cochrane review of six trials found PSA screening likely reduces prostate cancer deaths by about two per 1,000 men screened.

CDC confirms first U.S. human H5N1 bird flu case linked to exposure to infected dairy cattle in a Texas farm worker.